Cargando…
T regulatory cells as a potential therapeutic target in psychosis? Current challenges and future perspectives
Many studies have reported that patients with psychosis, even before drug treatment, have mildly raised levels of blood cytokines relative to healthy controls. In contrast, there is a remarkable scarcity of studies investigating the cellular basis of immune function and cytokine changes in psychosis...
Autores principales: | Corsi-Zuelli, Fabiana, Deakin, Bill, de Lima, Mikhael Haruo Fernandes, Qureshi, Omar, Barnes, Nicholas M., Upthegrove, Rachel, Louzada-Junior, Paulo, Del-Ben, Cristina Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611834/ https://www.ncbi.nlm.nih.gov/pubmed/34661175 http://dx.doi.org/10.1016/j.bbih.2021.100330 |
Ejemplares similares
-
Can (immune and other) gene expression help us to treat depression?
por: Mariani, Nicole
Publicado: (2021) -
Lost in translation. The quest for definitions of treatment-resistant depression with a focus on inflammation-related gene expression
por: Sforzini, Luca
Publicado: (2021) -
Minocycline in Major Depressive Disorder: And overview with considerations on treatment-resistance and comparisons with other psychiatric disorders
por: Nettis, Maria Antonietta
Publicado: (2021) -
Three's Company: Neuroimmune activation, sex, and memory at the tripartite synapse
por: Posillico, Caitlin K.
Publicado: (2021) -
Boosting stress resilience using flexibility as a framework to reduce depression risk
por: Madison, Annelise A.
Publicado: (2021)